吸入一酸化窒素市場：製品タイプ別、用途別、強さ別、エンドユーザー別、地域別

世界の吸入一酸化窒素市場は、2025年には13億1,000万米ドルと推定され、2032年には22億1,000万米ドルに達すると予測され、2025年から2032年にかけて7.7%のCAGR（複合年間成長率）で成長すると予測されています。

図.吸入一酸化窒素市場シェア（%）、2025年地域別

吸入一酸化窒素（iNO）は、低酸素性呼吸不全の新生児および臨月の新生児の治療薬として承認されている選択的肺血管拡張薬です。iNOは、肺血管を拡張し、換気と灌流のマッチングを改善し、肺高血圧を軽減することによって作用します。吸入すると、iNOは肺内で酸素および水と速やかに反応して二酸化窒素と硝酸塩を生成します。これらの分解産物は脂溶性ではないため、iNOは血流にほとんど入らず、全身の血管拡張を引き起こすことはないです。この選択的な肺血管拡張により、iNOは低酸素性呼吸不全の新生児において、換気と灌流のミスマッチを悪化させたり、全身性低血圧を引き起こしたりすることなく、酸素化を著しく改善することができます。

市場力学：

世界の吸入一酸化窒素市場成長の原動力は、新生児の早産と呼吸窮迫症候群の発生率の上昇です。例えば、2025年5月に世界保健機関（WHO）が報告したデータによると、未熟児は5歳未満の子供の死亡原因の第1位です。早産の合併症は2020年に約90万人の子どもの死亡を引き起こし、その75％は費用対効果の高い介入によって予防可能です。さらに、吸入一酸化窒素は、新生児の低酸素性呼吸不全に対する第一選択療法として、主要な臨床診療ガイドラインで推奨されるようになってきており、その結果、その採用が加速しています。しかし、iNO送達システムとボンベの法外な価格によって市場の成長は抑制される可能性があります。一方、成人の急性呼吸窮迫症候群（ARDS）のような他の肺疾患におけるiNOの有効性に関する進行中の調査は、市場拡大の有利な機会を提示しています。

この調査の主な特徴

本レポートでは、世界の吸入一酸化窒素市場を詳細に分析し、2024年を基準年とした予測期間（2025年～2032年）の市場規模（10億米ドル）と複合年間成長率（CAGR%）を掲載しています。

さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。

また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。

企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界の吸入一酸化窒素市場の主要企業をプロファイルしています。

本調査の対象となる主要企業には、Mallinckrodt plc、Linde PLC、日本酸素ホールディングス、SOL Group、Air Liquide S.A.、Air Water Inc.、Chemix Specialty Gases and Equipment、Vero Biotech LLC、Sichuan Salman Chemical Products Co、Chengdu Taiyu Industrial Gases Co., Ltd.、Bellerophon Therapeutics Inc.、Merck KGaA、GEヘルスケア、田辺三菱製薬、Messer Group、Nu-Med Plus Inc.、Beyond Air Inc.、Praxair Technology Inc.、Getinge Group、Circassia Pharmaceuticals。

このレポートからの洞察は、マーケティング担当者や企業の経営陣が、将来の製品発売、タイプアップ、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にするでしょう。

この調査レポートは、投資家、サプライヤー、製品メーカー、販売業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。

利害関係者は、世界の吸入一酸化窒素市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学、規制、動向分析

• 市場力学
• ドライバ
• 抑制要因
• 機会
• 影響分析
• 主な発展
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• PORTERの分析
• 合併と買収のシナリオ
• 業界動向

第4章 吸入一酸化窒素市場、製品タイプ別、2020年～2032年

• 吸入一酸化窒素送達システム
• 消耗品
• 一酸化窒素ボンベ
• 配送アクセサリ
• その他

第5章 吸入一酸化窒素市場、用途別、2020年～2032年

• 新生児呼吸器治療
• 慢性閉塞性肺疾患（COPD）
• 急性呼吸窮迫症候群（ARDS）
• 結核治療
• マラリア治療
• その他

第6章 吸入一酸化窒素市場、強さ別、2020年～2032年

• 100ppm
• 800ppm
• その他

第7章 吸入一酸化窒素市場、エンドユーザー別、2020年～2032年

• 病院
• 外来手術センター
• 在宅ケア設定

第8章 吸入一酸化窒素市場、地域別、2020年～2032年

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• Mallinckrodt plc
• Linde PLC
• Nippon Sanso Holdings Corporation
• SOL Group
• Air Liquide S.A.
• Air Water Inc.
• Chemix Specialty Gases and Equipment
• Vero Biotech LLC
• Sichuan Salman Chemical Products Co., Ltd.
• Chengdu Taiyu Industrial Gases Co., Ltd.
• Bellerophon Therapeutics Inc.
• Merck KGaA
• GE Healthcare
• Mitsubishi Tanabe Pharma Corporation
• Messer Group
• Nu-Med Plus Inc.
• Beyond Air Inc.
• Praxair Technology Inc.
• Getinge Group
• Circassia Pharmaceuticals

第10章 アナリストの推奨事項

• 運命の輪
• アナリストの見解
• 一貫性のある機会マップ

第11章 参考文献と調査手法

• 参考文献
• 調査手法
• 出版社について

Global Inhaled Nitric Oxide Market is estimated to be valued at USD 1.31 Bn in 2025 and is expected to reach USD 2.21 Bn by 2032, growing at a compound annual growth rate (CAGR) of 7.7% from 2025 to 2032.

Figure. Inhaled Nitric Oxide Market Share (%), By Region 2025

Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator approved for treating term and near-term neonates with hypoxic respiratory failure. iNO works by dilating pulmonary vessels, improving ventilation-perfusion matching, and reducing pulmonary hypertension. Upon inhalation, iNO rapidly reacts with oxygen and water in the lungs to produce nitrogen dioxide and nitrate. As these breakdown products are not lipid soluble, iNO has very little ability to enter the bloodstream and cause systemic vasodilation. This selective pulmonary vasodilation allows iNO to significantly improve oxygenation without worsening ventilation/perfusion mismatching or causing systemic hypotension in neonates with hypoxic respiratory failure.

Market Dynamics:

The global inhaled nitric oxide market growth is driven by the rising incidence of preterm births and respiratory distress syndrome among neonates. For Instance, in May 2025, according to the data reported by World Health Organization, prematurity is the leading cause of death among children under 5 years of age. Preterm birth complications caused around 900,000 child deaths in 2020, with 75% preventable through cost-effective interventions; global preterm birth rates in 2020 ranged from 4-16%. Moreover, inhaled nitric oxide has been increasingly recommended as the first-line therapy for hypoxic respiratory failure in newborns by leading clinical practice guidelines, thereby fuelling its adoption. However, the market growth can be restrained by the exorbitant price of iNO delivery systems and cylinders. On the other hand, ongoing research on the efficacy of iNO in other lung conditions like acute respiratory distress syndrome (ARDS) in adults presents lucrative opportunities for market expansion.

Key features of the study:

This report provides in-depth analysis of the global inhaled nitric oxide market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global inhaled nitric oxide market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Mallinckrodt plc, Linde PLC, Nippon Sanso Holdings Corporation, SOL Group, Air Liquide S.A., Air Water Inc., Chemix Specialty Gases and Equipment, Vero Biotech LLC, Sichuan Salman Chemical Products Co., Ltd., Chengdu Taiyu Industrial Gases Co., Ltd., Bellerophon Therapeutics Inc., Merck KGaA, GE Healthcare, Mitsubishi Tanabe Pharma Corporation, Messer Group, Nu-Med Plus Inc., Beyond Air Inc., Praxair Technology Inc., Getinge Group, and Circassia Pharmaceuticals.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global inhaled nitric oxide market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global inhaled nitric oxide market

Market Segmentation

• Product Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Inhaled Nitric Oxide Delivery Systems
  • Consumables
  • Nitric Oxide Cylinders
  • Delivery Accessories
  • Others
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Neonatal Respiratory Treatment
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Acute Respiratory Distress Syndrome (ARDS)
  • Tuberculosis Treatment
  • Malaria Treatment
  • Others
• Strength Insights (Revenue, USD Bn, 2020 - 2032)
  • 100 ppm
  • 800 ppm
  • Others
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care Settings
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Mallinckrodt plc
  • Linde PLC
  • Nippon Sanso Holdings Corporation
  • SOL Group
  • Air Liquide S.A.
  • Air Water Inc.
  • Chemix Specialty Gases and Equipment
  • Vero Biotech LLC
  • Sichuan Salman Chemical Products Co., Ltd.
  • Chengdu Taiyu Industrial Gases Co., Ltd.
  • Bellerophon Therapeutics Inc.
  • Merck KGaA
  • GE Healthcare
  • Mitsubishi Tanabe Pharma Corporation
  • Messer Group
  • Nu-Med Plus Inc.
  • Beyond Air Inc.
  • Praxair Technology Inc.
  • Getinge Group
  • Circassia Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Inhaled Nitric Oxide Market, By Product Type
  • Inhaled Nitric Oxide Market, By Application
  • Inhaled Nitric Oxide Market, By Strength
  • Inhaled Nitric Oxide Market, By End User
  • Inhaled Nitric Oxide Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Inhaled Nitric Oxide Market, By Product Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Inhaled Nitric Oxide Delivery Systems
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Consumables
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nitric Oxide Cylinders
• Delivery Accessories
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Inhaled Nitric Oxide Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Neonatal Respiratory Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chronic Obstructive Pulmonary Disease (COPD)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Acute Respiratory Distress Syndrome (ARDS)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Tuberculosis Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Malaria Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Inhaled Nitric Oxide Market, By Strength, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• 100 ppm
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• 800 ppm
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Inhaled Nitric Oxide Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ambulatory Surgical Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Home Care Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Inhaled Nitric Oxide Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Strength, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Mallinckrodt plc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Linde PLC
• Nippon Sanso Holdings Corporation
• SOL Group
• Air Liquide S.A.
• Air Water Inc.
• Chemix Specialty Gases and Equipment
• Vero Biotech LLC
• Sichuan Salman Chemical Products Co., Ltd.
• Chengdu Taiyu Industrial Gases Co., Ltd.
• Bellerophon Therapeutics Inc.
• Merck KGaA
• GE Healthcare
• Mitsubishi Tanabe Pharma Corporation
• Messer Group
• Nu-Med Plus Inc.
• Beyond Air Inc.
• Praxair Technology Inc.
• Getinge Group
• Circassia Pharmaceuticals

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us